4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-009271
CEO sold 17,714 shares at $17.90 ($317,081)
- CEO acquired 34,666 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2024-03-25 | Grant or award | +34,666 | 136,556 | D | ||
| DAVIS STEPHEN CEO | 2024-03-27 | Sale | −17,714 | $17.90 | $317,081 | 118,842 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2024-03-25 | Grant or award · Stock Option (Right to Buy) | +286,451 | 286,451 | D | ||
| Open-market sales · 17,714 sh · avg $17.90 · $317,081 | |||||||
Loading xslF345X05/form4-03272024_110307.xml…